ML
Therapeutic Areas
Aptevo Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Mipletamig (APVO436) | Acute Myeloid Leukemia (AML) | Phase 1/2 |
| ALG.APV-527 | Solid Tumors (5T4+) | Phase 1 |
| APVO603 | Solid Tumors | Preclinical |
| APVO711 | Solid Tumors | Preclinical |
| APVO442 | Prostate Cancer | Preclinical |
| APVO455 | Solid Tumors (Nectin-4+) | Preclinical |
| APVO451 | Solid Tumors (Nectin-4+) | Discovery |
| APVO452 | Prostate Cancer | Discovery |